Regression of left ventricular hypertrophy in essential arterial hypertension Reversión de la hipertrofia ventricular izquierda en la hipertensión arterial esencial.
Author
dc.contributor.author
Román Román, Pablo
Admission date
dc.date.accessioned
2019-01-29T15:49:57Z
Available date
dc.date.available
2019-01-29T15:49:57Z
Publication date
dc.date.issued
1994
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 122, Issue 3, 2018, Pages 333-338
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162499
Abstract
dc.description.abstract
The classic concept of a direct pathogenic relationship between high blood pressure and development of left ventricular hypertrophy has been challenged by observations such as the modest correlations between blood pressure and magnitude of left ventricular hypertrophy, its frequent reversal with some antihypertensive medications and its experimental prevention with low doses of an angiotensin-converting enzyme inhibitor that do not modify blood pressure. This evidence has prompted the revision of mechanisms or factors involved in the development of left ventricular hypertrophy. The roles of sympathetic nervous and renin-angiotensin systems, genetic and endothelial factors, are reviewed in this article. It is concluded that blood pressure is not the sole responsible for left ventricular hypertrophy, but an epiphenomenon of one or more local or tissular mechanisms, primary or unchained by an unknown genetic factor.
Regression of left ventricular hypertrophy in essential arterial hypertension Reversión de la hipertrofia ventricular izquierda en la hipertensión arterial esencial.